Pediatric BMT Program

THURSDAY FEBRUARY 12

A parallel track of sessions on hematopoietic stem cell transplants for children and adolescents will be held throughout the day on Thursday, February 12, at the 2009 BMT Tandem Meetings in Tampa.  The programs are coordinated by the ASBMT Pediatric BMT Special Interest Group and the Pediatric Blood and Marrow Transplant Consortium (PBMTC).

10:30 am
Preventing Relapse after Transplantation for Pediatric ALL – Peri-transplant, Targeted and Cellular Therapies
    Pre- and Post-Transplant Chemotherapy, Antibody and Targeted Therapies
         Michael Pulsipher, MD
    Minimal Residual Disease and Chimerism
         Peter Bader, MD, PhD
    Peri-Transplant Cellular Therapeutics
         Laurence J.N. Cooper, MD, PhD


12:30 pm
Pediatric International Session Symposium and Luncheon
Sandeep Soni, MD, Carmem Bonfim, MD, and Richard P. Kadota, MD, Co-Chairs

    Haplo-Identical Stem Cell Transplant Experience in China
         Xiaojun Huang, MD, PhD
    Innovative Supportive Care Practices in India
         Mammen Chandy, MD 

    Cord Blood Biology, Transplantation and Tissue Regeneration Applications in Israel
         Arnon Nagler, MD, MSc

1:45 pm
Transplant and Immunotherapies for Pediatric Solid Tumors 
   ■ Update on Autologous Stem Cell Transplantation for Neuroblastoma
         Stephan A. Grupp, MD, PhD
   ■ Can Antibody Therapy Replace Autologous Stem Cell Transplantation for
     
Neuroblastoma
         Brian H. Kushner, MD
   Cell and Vaccine-Based Therapies for High-Risk Pediatric Cancers
         Alan S. Wayne, MD 

1:45 pm
Transplant vs. Non-Transplant for Treatment of Challenging Hematological Disorders
   Paroxysmal Nocturnal Hemoglobinuria (PNH)
         Charles J. Parker, MD
   ■ Hypoplastic Myelodysplastic Syndrome/Aplastic Anemia
         Robert A. Brodsky, MD
   ■ Kostmann’s Syndrome

         John Levine, MD

3:20 pm
Controversies of and Unique Issues in BMT Infant Leukemia
Kirk R. Schultz, MD, Chair
   Juvenile Myelomonocytic Leukemia:  From Bench to Beside and Back Again
         Mignon L. Loh, MD

  
Infant Leukemia:  Is Transplantation the Answer?
         Steve P. Hunger, MD

  
Special Considerations and Complications Related to the Long-Term Outcome after
      Infant BMT

         Scott Baker, MD


3:20 pm

Wiskott Aldrich Syndrome
Neena Kapoor, MD, and Morton J. Cowan, MD, Co-Chairs 
   Biology, Phenotype, Genotype of WAS
         Hans D. Ochs, MD

  
Update of Treatment Outcome of WAS – the US Experience
         Alexandra H. Filipovich, MD

  
Transplant Outcome of Reduced-Intensity Conditioning for WAS
         Paul Veys, MD


5:05 pm
Pediatric Best Abstracts

6:15 pm

Pediatric Posters  (Included in Poster Session I)

7:30 pm
Meeting of the Pediatric Blood and Marrow Transplant Consortium (PBMTC)